TITLE

A novel case with germline p53 gene mutation having concurrent multiple primary colon tumours

AUTHOR(S)
Miyaki, M.; Iijima, T.; Ohue, M.; Kita, Y.; Hishima, T.; Kuroki, T.; Iwama, T.; Mori, T.
PUB. DATE
February 2003
SOURCE
Gut;Feb2003, Vol. 52 Issue 2, p304
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
During a search for causative genes in patients with concurrent multiple primary colon tumours, we found a novel case with a germline mutation of the p53 gene, from GCC (Ala) to GTC (Val) at codon 189. Of the six primary colon tumours that this patient had, one large advanced carcinoma exhibited a somatic p53 mutation and a somatic APC mutation, in addition to the germline p53 mutation. Two early carcinomas and three adenomas had somatic APC mutations but no somatic p53 mutation or loss of the p53 allele. K-ras-2 mutations were detected in an advanced carcinoma and an early carcinoma. The present results suggest that a patient with a certain type of germline p53 mutation is predisposed to concurrent multiple colon tumours. It is also suggested that in such a patient, a somatic APC mutation is involved in tumour formation and that an additional somatic p53 mutation contributes to tumour progression.
ACCESSION #
9704726

 

Related Articles

  • Investigations on a clinically and functionally unusual and novel germline p53 mutation. Rutherford, J.; Chu, C.E.; Duddy, P.M.; Charlton, R.S.; Chumas, P.; Taylor, G.R.; Lu, X.; Barnes, D.M.; Camplejohn, R.S. // British Journal of Cancer;5/20/2002, Vol. 86 Issue 10, p1592 

    This report describes an individual with a rare choroid plexus papilloma in adulthood (age 29) after earlier having an osteosarcoma (age 22). The results from this study, and others, suggest that it may be advisable to consider the possibility of a germline p53 mutation in adults presenting with...

  • The p53 Mutation Which Abrogates Trans-Activation While Maintaining Its Growth-Suppression Activity. Sang-Jin Oh; Min-Young Im // Molecules & Cells (Springer Science & Business Media B.V.);2000, Vol. 10 Issue 4, p386 

    Presents a study which focused on the p53 mutation which abrogates trans-activation while maintaining its growth-suppression activity. Materials and methods; Results; Discussion.

  • Characterization of sequence elements involved in p53 stability regulation reveals cell type dependence for p53 degradation. Hengstermann, Arnd; Whitaker, Noel J; Zimmer, Dagmar; Zentgraf, Hanswalter; Scheffner, Martin // Oncogene;12/3/98, Vol. 17 Issue 22, p2933 

    The growth suppressive properties of the tumor suppressor protein p53 are activated upon DNA damage. The activation of p53 is reflected in increased p53 levels which are, at least in part, the result of an extended half-life of the protein. Although this suggests that stabilization of p53 is an...

  • Novel p53 splice site mutations in three families with Li-Fraumeni syndrome. Verselis, Sigitas J; Rheinwald, James G; Fraumeni, Joseph F; Li, Frederick P // Oncogene;8/31/2000, Vol. 19 Issue 37, p4230 

    Germline mutations in the p53 tumor suppressor gene predispose to a variety of cancers in families with Li-Fraumeni syndrome. Most germline p53 mutations observed to date cause amino acid substitutions in the protein's central sequence-specific DNA binding domain. Outside this conserved core...

  • Mutations of the p53 gene in canine lymphoma and evidence for germ line p53 mutations in the dog. Veldhoen, Nik; Stewart, Jane; Brown, Robert; Milner, Jo // Oncogene;1/15/98, Vol. 16 Issue 2, p249 

    Mutations of the p53 gene are associated with a number of non-lymphoid cancers of the dog. The present study investigates the p53 gene status within canine patients treated for primary and secondary lymphoma. Three out of eight patients exhibited p53 gene mutations. These included one patient...

  • Degenerated pIX-IVa2 adenoviral vector sequences lowers reacquisition of the E1 genes during virus amplification in 293 cells. Robert, J-J; Gauffeny, I; Maccario, J; Jullien, C; Benoit, P; Vigne, E; Crouzet, J; Perricaudet, M; Yeh, P // Gene Therapy;Nov2001, Vol. 8 Issue 22, p1713 

    A critical issue for E1-deleted adenoviral vectors manufactured from 293 cells is the emergence of replication-competent adenovirus (RCA). These contaminants arise through homologous recombination between identical sequences framing the E1 locus displayed by 293 cells, and the vector backbones....

  • Characterization of p53 oligomerization domain mutations isolated from Li—Fraumeni and Li—Fraumeni like family members. Lomax, M E; Barnes, D M; Hupp, T R; Picksley, S M; Camplejohn, R S // Oncogene;8/6/98, Vol. 17 Issue 5, p643 

    P53: is a tumour suppressor gene which functions as a transcription factor to upregulate genes for growth arrest and apoptosis following DNA damage. p53 mutations are associated with Li–Fraumeni and Li–Fraumeni like syndromes. Recently mutations of the oligomerization domain have...

  • Mutation and Abnormal Expression of the p53 Gene in the Viral Skin Carcinogenesis of Epidermodysplasia Verruciformis. Padlewska, Kamila; Ramoz, Nicolas; Cassonnet, Patricia; Riou, Guy; Barrois, Michel; Majewski, Slavomir; Croissant, Odile; Jablonska, Stefania; Orth, Gérard // Journal of Investigative Dermatology;Oct2001, Vol. 117 Issue 4, p935 

    Patients suffering from epidermodysplasia verruciformis are prone to nonmelanoma skin cancers, due to an inherited abnormal susceptibility to the oncogenic human papillomavirus type 5. Genotoxic sunlight ultraviolet B radiations are likely to be a cofactor. Lesions of two...

  • No concomitant occurrence of the N-ras and p53 gene mutations in myelodysplastic syndromes. Mitani, K; Hangaishi, A; Imamura, N; Miyagawa, K; Ogawa, S; Kanda, Y; Yazaki, Y; Hirai, H // Leukemia (08876924);Jun97, Vol. 11 Issue 6, p863 

    Mutations of the N-ras oncogene and p53 tumor suppressor gene were simultaneously investigated in bone marrow cells from 44 patients with myelodysplastic syndrome (MDS) or MDS-derived leukemia by single-strand conformation polymorphism (SSCP) analysis followed by direct sequencing. The mutations...

  • New Leads Suggest a Clinically Relevant Genotype-Phenotype Relationship for the p53 Gene. Kaye, Frederic J.; Komiya, Takefumi // JNCI: Journal of the National Cancer Institute;7/02/2003, Vol. 95 Issue 13, p926 

    Editorial. Comments on an article on the relationship between p53 mutations and non-small cell lung cancer, published in the July 2, 2003 issue of the 'Journal of the National Cancer Institute.' Detection of p53 mutations in 50 percent of the primary lung samples; Reasons for the difficulty in...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sign out of this library

Other Topics